103 related articles for article (PubMed ID: 20662847)
101. The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders.
Musto P; D'Auria F
Expert Opin Biol Ther; 2011 May; 11(5):551-7. PubMed ID: 21385115
[TBL] [Abstract][Full Text] [Related]
102. Orbital lymphoproliferative disorders.
Garner A
Br J Ophthalmol; 1992 Jan; 76(1):47-8. PubMed ID: 1739692
[No Abstract] [Full Text] [Related]
103. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
Kojima M; Motoori T; Asano S; Nakamura S
Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
